loading page

Leukemia mortality in children and adolescents from Latin America: Trends and predictions to 2032.
  • +5
  • J Torres-Roman,
  • Bryan Valcarcel,
  • Pedro Guerra Canchari,
  • Camila Alves Dos Santos,
  • Isabelle Ribeiro Barbosa Ribeiro Barbosa,
  • Carlo La Vecchia,
  • Katherine McGlynn,
  • Dyego Bezerra de Souza
J Torres-Roman
Unidad de Investigación Básica y Traslacional, Oncosalud-AUNA

Corresponding Author:[email protected]

Author Profile
Bryan Valcarcel
Milken Institute School of Public Health, The George Washington University
Author Profile
Pedro Guerra Canchari
Universidad Nacional Mayor de San Marcos
Author Profile
Camila Alves Dos Santos
Graduate Program in Collective Health, Federal University of Rio Grande do Norte. Natal, Rio Grande do Norte state
Author Profile
Isabelle Ribeiro Barbosa Ribeiro Barbosa
Graduate Program in Collective Health, Federal University of Rio Grande do Norte. Natal, Rio Grande do Norte state, Brazil.
Author Profile
Carlo La Vecchia
Department of Clinical Sciences and Community Health, Università degli Studi di Milano 20133, Milan, Italy.
Author Profile
Katherine McGlynn
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Author Profile
Dyego Bezerra de Souza
Graduate Program in Collective Health, Federal University of Rio Grande do Norte. Natal, Rio Grande do Norte state, Brazil.
Author Profile

Abstract

Background: Leukemia remains the leading cause of cancer-related death in Latin American (LA) children and adolescents. The aim is to evaluate leukemia mortality trends in children and adolescents (0-19y) from 13 LA countries in the last two decades and to predict mortality to 2032. Methods: We retrieved cancer mortality data through World Health Organization Mortality Database. Age-standardized (world standard population) rates were computed for 13 LA countries 2000–2017. Mortality trends were analyzed by Joinpoint regression, and Nordpred was utilized for the calculation of predictions. Results: Ecuador and Mexico had the highest mortality among LA countries. For boys, Ecuador continues to increase in 1.5% annually, while Mexico reported a decline by −0.3% annually. For both genders, Nicaragua showed a high rise, for boys (APC= +3.1) and for girls (APC= +2.3), while Puerto Rico experienced a large decrease, for boys (APC= −9.7), and girls ( APC= −6.0). The comparison between the last observed and projected period showed a greater increase in the risk of death from leukemia in Ecuador and Argentina for boys, and Nicaragua and Peru for girls. In Puerto Rico, there was a reduction in the percentage of cases associated with changes in size and population structure, despite the increased risk of death from leukemia. Conclusion: Ecuador and Mexico continue to report the highest mortality for leukemia among LA countries. However, in the last years, Mexico has shown favorable changes in mortality. Special attention should be given to Ecuador due to the significant increase in mortality rates.